Kansai and Alloy are in a Collaboration to Leverage Growth in Japan Announcement Kansai Startup Academia Coalition, represented by Kyoto University, fostered to expansion university university-affiliated life science startups throughout Japan, and Alloy Therapeutics co, Ltd. has signed a memoran...
QIAGEN Enhances its Portfolio with Long-read Panels Announcement Qiagen has introduced new QIAseq xHYB long-read panels, a groundbreaking solution designed to explore the long-read sequencing of genomically complex regions. This sequencing idea strongly builds Qiagen’s position as a provid...
Hengrui and IDEAYA Bioscience’s Publication for a Presentation at IASLC 2025 Announcement Jiangsu Hengrui Pharmaceuticals co ltd a pharmaceutical company known for its technological and scientific innovation, and IDEAYA Biosciences Inc., a global precision medicine oncology company, showca...
AAVnerGene and Klotho’s Alliance Announcement AVVnerGene Inc., a Rockville, MD innovation-fueled biotech known for its remarkable technologies in AAV tissue-targeted delivery and manufacturing, and Klotho Neurosciences Inc. have entered a partnership to enhance the product’s potentia...
Cycle and Handa Signed an Exclusive Sales License Agreement Announcement Cycle Pharmaceuticals signed a us commercialization (sales) agreement with Handa Therapeutics LLC for PHYRAGO distribution (availability). The PHYRAGO is an FDA-approved drug for the treatment of the two types of leukemia, ...
Sarepta Therapeutics Pauses ELEVIDYS Shipments in the US to Play a Vital Role Announcement Sarepta Therapeutics, Inc., a known producer of precision genetic medicine for rare diseases, decided to temporarily and voluntarily halt all shipments in the United States for Elevidys (delandistrogene mo...
AstraZeneca Intends to Invest in America Announcement AstraZeneca plans to invest approximately $50 billion in the United States by around 2030 to manufacture medicines and boost its research and development efforts. The investment will unlock skilled indirect or direct jobs across the region th...
AusperBio Phase 3 Clinical Trial Approved by CDE Announcement Ausperbio Therapeutics Inc. and Ausper Biopharma Co., Ltd (merged Ausperbio), a biotechnology company known for the advancement in oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, received approval to perform a...
NKGen Biotech and HekaBio Came Together to Bring New NK Cell Therapy to Japan Announcement NKGen Biotech, a US-headquartered clinical-stage biotechnology company with a strong focus on the development and commercialization of novel autologous and allogenic natural killer (NK) cell therapies, ann...
Korea’s CoresteamChemo & ATG Lifetech came Together to Expand the CRO’s Global Reach Partnership Overview A South Korea-based, leading GLP-certified preclinical CRO, CoresteamChemo, and a biotechnology company specialized in transcriptome analytics and organoid-based modeling, AT...
